Callan Family Office’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.05M Buy
11,135
+900
+9% +$89.8K 0.02% 548
2025
Q4
$1.01M Buy
10,235
+4,197
+70% +$406K 0.02% 544
2025
Q3
$512K Sell
6,038
-3,295
-35% -$260K 0.02% 523
2025
Q2
$636K Buy
+9,333
New +$591K 0.02% 513

Other funds holding INCY

Callan Family Office's INCY Position: Q1 2026 in Review

Callan Family Office increased its Incyte (INCY) stake by 8.8% in Q1 2026, buying an estimated $89.8K and bringing the position to 11,135 shares worth $1.05M. The position accounts for 0.02% of the portfolio, ranked #548.

Callan Family Office first reported a position in INCY in Q2 2025 and has held it in 4 quarters since. 810 funds tracked by Wall St. Rank hold INCY as of Q1 2026.

  • Callan Family Office held 11,135 shares of Incyte worth $1.05M as of Q1 2026.
  • Callan Family Office bought 900 Incyte shares in Q1 2026, an estimated $89.8K.
  • Incyte made up 0.02% of Callan Family Office's portfolio in Q1 2026, its #548 holding.
  • Callan Family Office first reported a position in Incyte in Q2 2025 and has held it in 4 quarters since.
  • 810 funds tracked by Wall St. Rank held Incyte as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.